Impact of biological therapy on spondyloarthritis Nicola MaruottiFrancesco Paolo Cantatore Review Article 10 June 2014 Pages: 1021 - 1027
Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention Atefeh JafariHossein KhaliliSimin Dashti-Khavidaki Review Article 25 June 2014 Pages: 1029 - 1040
Gene polymorphism of cytochrome P450 2C19*2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis Xiaowen HouJingpu ShiHao Sun Review Article 05 July 2014 Pages: 1041 - 1047
Prasugrel but not high dose clopidogrel overcomes the lansoprazole neutralizing effect of P2Y12 inhibition: Results of the randomized DOSAPI study Jean-Philippe ColletJean-Sébastien Hulotfor the DOSAPI investigators. Clinical Trial 12 July 2014 Pages: 1049 - 1057
Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations José-Francisco RochaAmílcar FalcãoPatrício Soares-da-Silva Pharmacodynamics 14 June 2014 Pages: 1059 - 1071
Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese Mitsushige SugimotoNaohito ShiraiTakahisa Furuta Pharmacodynamics 06 July 2014 Pages: 1073 - 1078
N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group Ching-Soon NgAbul HasnatAnn K. Daly Pharmacogenetics 03 June 2014 Pages: 1079 - 1086
Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers Yumiko AkamineMasatomo MiuraNorio Yasui-Furukori Pharmacokinetics and Disposition 07 June 2014 Pages: 1087 - 1095
Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins Kyra J. BarnesAndrew RowlandJohn O. Miners Pharmacokinetics and Disposition 24 June 2014 Pages: 1097 - 1106
Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone Wen H. LinHwa-Ping FengJoan R. Butterton Pharmacokinetics and Disposition 05 July 2014 Pages: 1107 - 1113
Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions Ben D. SnyderAndrew RowlandMatthew P. Doogue Pharmacokinetics and Disposition 17 July 2014 Pages: 1115 - 1122
Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database François MontastrucCannelle DuguetJean-Louis Montastruc Pharmacoepidemiology and Prescription 14 June 2014 Pages: 1123 - 1127
Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures Arianna GhirardiMauro Di BariThis study is on behalf of the BEST investigators Pharmacoepidemiology and Prescription 22 June 2014 Pages: 1129 - 1137
Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations Marit TveitoJørgen G. BramnessGudrun Høiseth Pharmacoepidemiology and Prescription 18 July 2014 Pages: 1139 - 1145
Atropinic burden of prescription forms in France: a study in community pharmacies in 2013 François MontastrucElodie RetailleauJean-Louis Montastruc Letter to the Editors 12 July 2014 Pages: 1147 - 1148
